°Ö Àü±â¿µµ¿ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 25¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °Ö Àü±â¿µµ¿ ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.3%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 25¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½ÇÇè½Ç ¿¬±¸ ÃÖÁ¾ ¿ëµµ ºÎ¹®Àº CAGR 5.3%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 12¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷ ÃÖÁ¾»ç¿ë ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È CAGR 5.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀå 4¾ï 8,280¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.2%·Î ¼ºÀå Àü¸Á
¹Ì±¹ÀÇ °Ö Àü±â¿µµ¿ ½ÃÀåÀº 2024³â 4¾ï 8,280¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 8.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 7,520¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.1%¿Í 4.2%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è °Ö Àü±â¿µµ¿ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à
°Ö Àü±â¿µµ¿ÀÌ Çö´ë ºÐÀÚ»ý¹°ÇÐ ¹× ¿¬±¸¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?
°Ö Àü±â¿µµ¿Àº ºÐÀÚ»ý¹°ÇÐ ¹× »ýÈÇÐÀÇ ±âÃÊ ±â¼úÀ̸ç, ÇÙ»ê(DNA, RNA) ¹× ´Ü¹éÁúÀÇ ºÐ¼®°ú ºÐ¸®¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ±×·¸´Ù¸é ¿Ö ÀÌ ±â¼úÀÌ Çö´ë °úÇÐ ¿¬±¸¿¡¼ ¸Å¿ì Áß¿äÇÑ °ÍÀϱî? °Ö Àü±â¿µµ¿ÀÌ Áß¿äÇÑ ÀÌÀ¯´Â °úÇÐÀÚµéÀÌ ºÐÀÚÀÇ Å©±â, ÀüÇÏ, ¸ð¾ç¿¡ µû¶ó ºÐÀÚ¸¦ ºÐ¸®ÇÏ¿© À¯Àü ¹°Áú°ú ´Ü¹éÁúÀ» Á¤È®ÇÏ°Ô ½Ã°¢È, Á¤·®È, ºÐ¼®ÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ ±â¼úÀº À¯ÀüÀÚ Áö¹® ¹× ¹ýÀÇÇÐ ºÐ¼®ºÎÅÍ À¯ÀüÀÚ º¹Á¦, À¯Àü°øÇÐ, ´Ü¹éÁú ¿¬±¸¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
DNA ºÐ¼®¿¡¼ °Ö Àü±â¿µµ¿Àº À¯ÀüÀÚ ¿¬±¸ ¹× ºÐÀÚ Å¬·Î´×¿¡¼ ÇʼöÀûÀÎ ´Ü°èÀÎ ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR) ¹× Á¦ÇÑÈ¿¼Ò ¼ÒÈÀÇ ¼º°ø ¿©ºÎ¸¦ È®ÀÎÇÏ´Â µ¥ ƯÈ÷ Áß¿äÇÕ´Ï´Ù. ¿¬±¸ÀÚµéÀº DNA Á¶°¢ÀÇ Á¸Àç, Å©±â, ¿ÏÀü¼ºÀ» È®ÀÎÇϱâ À§ÇØ À̸¦ »ç¿ëÇÏ¿© À¯ÀüÀÚ ¸ÅÇÎ, À¯ÀüÀÚ º¯ÀÌ Á¶»ç ¶Ç´Â ¹ýÀÇÇÐ »ç°Ç¿¡¼ °³ÀÎÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´Ü¹éÁú ¿¬±¸¿¡¼ °Ö Àü±â¿µµ¿Àº ´Ü¹éÁúÀÇ ¼øµµ, ºÐÀÚ·® ¹× ±¸Á¶¸¦ °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀǾàǰ °³¹ß ¹× Áø´Ü ÀÀ¿ë¿¡ ÇʼöÀûÀÔ´Ï´Ù. °Ö Àü±â¿µµ¿Àº ³ôÀº Ȱ¿ë¼º°ú Á¤È®¼ºÀ¸·Î ÀÎÇØ ºÐÀÚ»ý¹°ÇÐ ¿¬±¸ÀÇ ÇÙ½ÉÀ̸ç, À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ¸ÂÃãÀÇ·á ºÐ¾ß¿¡¼ ȹ±âÀûÀÎ ¹ßÀüÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.
±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô °Ö Àü±â¿µµ¿À» Çâ»ó½Ã۰í Àִ°¡?
°Ö Àü±â¿µµ¿ÀÇ ±â¼úÀû ¹ßÀüÀº Á¤È®¼º, ¼Óµµ ¹× »ç¿ë ÆíÀǼºÀ» Å©°Ô Çâ»ó½ÃÄÑ ºÐÀÚ »ý¹°ÇÐ ¹× »ýÈÇÐ ¿¬±¸¸¦ À§ÇÑ ´õ¿í °·ÂÇÑ µµ±¸°¡ µÇ¾ú½À´Ï´Ù. ÁÖ¿ä ±â¼ú Çõ½Å Áß Çϳª´Â ÀÚµ¿ Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ °³¹ßÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ½Ã·á ·Îµù¿¡¼ À̹Ì¡±îÁö Àü±â¿µµ¿ÀÇ ¸ðµç ´Ü°è¸¦ °£¼ÒÈµÈ ÀÚµ¿ÈµÈ ÇÁ·Î¼¼½º·Î ÅëÇÕÇÕ´Ï´Ù. ÀÚµ¿È ½Ã½ºÅÛÀº ÀÎÀû ¿À·ù¸¦ ÁÙÀ̰í, ÀϰüµÈ °á°ú¸¦ Á¦°øÇϰí, ¿©·¯ »ùÇÃÀ» µ¿½Ã¿¡ ºÐ¼®ÇÒ ¼ö ÀÖÀ¸¸ç, ½ÇÇè½Ç 󸮷®°ú È¿À²¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.
¶Ç ´Ù¸¥ Å« ¹ßÀüÀº °Ö Àç·áÀÇ °³¼±ÀÔ´Ï´Ù. ÀüÅëÀûÀÎ ¾Æ°¡·Î½º ¹× Æú¸®¾ÆÅ©¸±¾Æ¹Ìµå Á©Àº ¿©ÀüÈ÷ ³Î¸® »ç¿ëµÇ°í ÀÖÁö¸¸, ´õ ³ªÀº ÇØ»óµµ¿Í ºü¸¥ ·±Å¸ÀÓÀ» °¡Áø »õ·Î¿î Á©ÀÌ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÇÁ¸®Ä³½ºÆ® Á©Àº ¹Ì¸® ÁغñµÈ Á©·Î, ¿¬±¸ÀÚ°¡ Á÷Á¢ Á©À» ÁغñÇÒ Çʿ䰡 ¾ø½À´Ï´Ù. ÇÁ¸®Ä³½ºÆ® Á©Àº ¶ÇÇÑ µÎ²²¿Í ±¸¼ºÀÌ ´õ ±ÕÀÏÇÏ¿© º¸´Ù Á¤È®Çϰí ÀçÇö¼º ÀÖ´Â °á°ú¸¦ º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, ¹Ðµµ°¡ ´Ù¸¥ ±×¶óµð¾ðÆ® °ÖÀÇ °³¹ß·Î µ¿ÀÏÇÑ ½Ã·á¿¡¼ ¼·Î ´Ù¸¥ Å©±âÀÇ ºÐÀÚ¸¦ º¸´Ù Á¤È®ÇÏ°Ô ºÐ¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾î °á°úÀÇ Åõ¸í¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.
Çü±¤ ¿°»ö ±â¼úÀº °Ö Àü±â ¿µµ¿¿¡¼ ¶Ç ´Ù¸¥ ȹ±âÀûÀÎ ±â¼úÀÔ´Ï´Ù. ¿¡Æ¼µð¿ò ºê·Î¸¶À̵å¿Í °°Àº ÀüÅëÀûÀÎ ¿°»öÀº ´õ ÀûÀº ¾çÀÇ ÇÙ»ê°ú ´Ü¹éÁúÀ» °ËÃâÇÒ ¼ö ÀÖ´Â ´õ ¾ÈÀüÇÏ°í ¹Î°¨ÇÑ Çü±¤ ¿°·á·Î ´ëüµÇ¾ú½À´Ï´Ù. ÀÌ ¿°·á´Â ¿øÇÏ´Â ºÐÀÚ¿¡ °áÇÕÇÏ¿© ƯÁ¤ ÆÄÀåÀÇ ºûÀ» Á¶»çÇÏ¸é ¹àÀº Çü±¤ ½ÅÈ£¸¦ ¹ß»êÇϱ⠶§¹®¿¡ ¹Ì·®ÀÇ ¹°Áúµµ ½±°Ô °ËÃâÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹Î°¨µµ´Â Á¤È®ÇÑ Á¤·®ÀÌ ÇʼöÀûÀÎ Â÷¼¼´ë ½ÃÄö½Ì ¹× ´Ü¹éÁúüÇаú °°Àº ÀÀ¿ë ºÐ¾ß¿¡¼ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.
¶ÇÇÑ, Àü±â¿µµ¿ ¿ÏÃæ¾× ¹× ¿Âµµ Á¦¾î ½Ã½ºÅÛ°ú °°Àº ÀÛµ¿ Á¶°ÇÀÇ ¹ßÀüÀº ºÐ¸® °úÁ¤¿¡¼ ¹Î°¨ÇÑ »ýü ºÐÀÚÀÇ ¿È¸¦ ¹æÁöÇÏ¿© °Ö Àü±â¿µµ¿ÀÇ ½Å·Ú¼ºÀ» ´õ¿í Çâ»ó½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀ¸·Î °Ö Àü±â¿µµ¿Àº ´õ¿í °ß°íÇϰí Á¤È®ÇÏ¸ç »ç¿ëÇϱ⠽¬¿öÁ® À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, ºÐÀÚÁø´ÜÇÐ µî ÷´Ü ¿¬±¸ ºÐ¾ß¿¡¼ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.
¿Ö °Ö Àü±â¿µµ¿ÀÌ DNA, RNA, ´Ü¹éÁú Á¶»ç ¹× Áø´Ü¿¡ ÇʼöÀûÀΰ¡?
°Ö Àü±â¿µµ¿Àº DNA, RNA, ´Ü¹éÁú ºÐ¼®, ƯÈ÷ Á¤¹Ðµµ¿Í Á¤È®µµ°¡ °¡Àå Áß¿äÇÑ ¿¬±¸ ¹× Áø´Ü ÇöÀå¿¡¼ ÇʼöÀûÀ̸ç, DNA¿Í RNA ºÐ¼®¿¡¼ °Ö Àü±â¿µµ¿Àº ÇÙ»êÀ» Å©±âº°·Î ºÐ¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â PCRÀ̳ª Á¦ÇÑÈ¿¼Ò ºÐÇØ¿Í °°Àº ±â¼ú ÈÄ¿¡ À¯Àü ¹°ÁúÀ» ½Ã°¢ÈÇϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÌ ºÐ¸®¸¦ ÅëÇØ ¿¬±¸ÀÚµéÀº ƯÁ¤ DNA ¶Ç´Â RNA Á¶°¢ÀÇ Á¸À縦 È®ÀÎÇϰí, ±× ǰÁúÀ» Æò°¡Çϰí, À¯ÀüÀÚ ¸ÅÇÎ, Ŭ·Î´× ¹× ½ÃÄö½Ì¿¡¼ Áß¿äÇÑ ¿ä¼ÒÀÎ Å©±â¸¦ °áÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹ýÀÇÇп¡¼ °Ö Àü±â¿µµ¿Àº DNA Áö¹®¿¡µµ »ç¿ëµÇ¸ç, DNA Á¶°¢ÀÇ °íÀ¯ÇÑ ÆÐÅÏÀ» »ç¿ëÇÏ¿© °³ÀÎÀ» ½Äº°ÇÏ°í °ü°è¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.
´Ü¹éÁú ¿¬±¸¿¡¼ °Ö Àü±â¿µµ¿Àº ´Ü¹éÁúÀÇ Á¶¼º, ±¸Á¶, ±â´ÉÀ» ºÐ¼®ÇÏ´Â µ¥ ÇʼöÀûÀ̸ç, SDS-PAGE(Sodium Dodecyl Sulfate Polyacrylamide gel electrophoresis)¿Í °°Àº ±â¼úÀ» ÅëÇØ ´Ü¹éÁúÀ» ºÐÀÚ·®¿¡ µû¶ó ºÐ¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù. °úÇÐÀÚµéÀº º¹ÀâÇÑ È¥ÇÕ¹°¿¡¼ °³º° ´Ü¹éÁúÀ» ¿¬±¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â ¿¬±¸ÀÚ°¡ Áúº´ °æ·Î¿¡ °ü¿©Çϴ ƯÁ¤ ´Ü¹éÁúÀ» ºÐ¸®ÇÏ°í ¿¬±¸ÇØ¾ß ÇÏ´Â ÀǾàǰ °³¹ß¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ, °Ö Àü±â¿µµ¿Àº ´Ü¹éÁúÀÇ ¼øµµ Æò°¡ ¹× ¹ø¿ª ÈÄ º¯Çü °ËÃâ¿¡µµ »ç¿ëµË´Ï´Ù. ÀÌ´Â »ýÈÇÐ ¿¬±¸ ¹× Ä¡·áÁ¦ °³¹ß¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.
¶ÇÇÑ, °Ö Àü±â¿µµ¿Àº À¯ÀüÀÚ Áúȯ, ¾Ï, °¨¿°¼º ÁúȯÀÇ Áø´Ü¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ³¶Æ÷¼º¼¶À¯ÁõÀ̳ª °â»ó ÀûÇ÷±¸ ºóÇ÷°ú °°Àº Áúº´°ú °ü·ÃµÈ À¯ÀüÀÚ µ¹¿¬º¯À̸¦ ½Äº°ÇÏ´Â µ¥ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ȯÀÚÀÇ »ùÇÿ¡¼ DNA¿Í RNA¸¦ ºÐ¸®ÇÏ°í ºÐ¼®ÇÔÀ¸·Î½á ÀÓ»óÀǴ ƯÁ¤ À¯ÀüÀÚ ÀÌ»óÀ» ã¾Æ³»¾î Á¤È®ÇÑ Áø´Ü°ú °³Àκ° ¸ÂÃã Ä¡·á °èȹÀ» ¼¼¿ï ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿þ½ºÅϺí·Ô°ú °°Àº Àü±â¿µµ¿ ±â¹Ý ±â¼úÀº ÀÚ°¡¸é¿ªÁúȯÀÇ Ç×ü, HIV¿Í °°Àº °¨¿°¼º ÁúȯÀÇ ¹ÙÀÌ·¯½º¼º ´Ü¹éÁú°ú °°Àº Áúº´°ú °ü·ÃµÈ ´Ü¹éÁúÀ» °ËÃâÇϱâ À§ÇØ ÀÓ»ó Áø´Ü¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
¿ä¾àÇϸé, ¿¬±¸ ¹× Áø´Ü ºÐ¾ß¿¡¼ »ý¹°ÇÐÀû ºÐÀÚ¸¦ ³ôÀº Á¤È®µµ·Î ºÐ¸®ÇÏ°í ºÐ¼®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» Á¦°øÇÏ´Â ±âº» µµ±¸ÀÔ´Ï´Ù. ÇÙ»ê°ú ´Ü¹éÁúÀ» ´Ù·ê ¶§ ´ÙÀç´Ù´ÉÇϰí È¿°úÀûÀ̱⠶§¹®¿¡ À¯ÀüÇÐ, Áúº´ ±âÀü, ÀǾàǰ °³¹ßÀÇ ÀÌÇØ¸¦ ÁõÁø½ÃŰ´Â µ¥ Áß¿äÇÑ ±â¼úÀÌ µÇ¾ú½À´Ï´Ù.
°Ö Àü±â¿µµ¿ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
°Ö Àü±â¿µµ¿ ½ÃÀåÀº ºÐÀÚÁø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, À¯Àüü ¿¬±¸ÀÇ ¹ßÀü, º¸´Ù È¿À²ÀûÀ̰í Á¤¹ÐÇÑ °Ë»ç ±â¼ú¿¡ ´ëÇÑ ¿ä±¸°¡ ¸Â¹°·Á °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â DNA, RNA, ´Ü¹éÁú ºÐ¼®¿¡ Àü±â¿µµ¿À» ¸¹ÀÌ »ç¿ëÇÏ´Â À¯ÀüüÇÐ ¹× ´Ü¹éÁúüÇÐ ºÐ¾ßÀÇ È®´ëÀÔ´Ï´Ù. ¿¬±¸ÀÚµéÀÌ À¯ÀüÀÚ ¹ßÇö Á¶»ç, À¯ÀüÀÚ ¸ÅÇÎ, ¸ÂÃãÇü ÀǷḦ ±íÀÌ ÆÄ°íµé¸é¼ °Ö Àü±â¿µµ¿°ú °°Àº ½Å·ÚÇÒ ¼ö ÀÖ°í Á¤È®ÇÑ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
µÑ°, ºÐÀÚÁø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. À¯Àü¼º Áúȯ, ¾Ï, °¨¿°¼º ÁúȯÀÌ Á¡Á¡ ´õ ³Î¸® ÆÛÁö¸é¼ ÀÇ·á ¼ºñ½º Á¦°øÀÚµéÀº ÀÌ·¯ÇÑ ÁúȯÀ» Á¤È®ÇÏ°Ô ½Äº°Çϰí Ä¡·áÇϱâ À§ÇØ ºÐÀÚÁø´Ü ±â¼ú¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. °Ö Àü±â¿µµ¿Àº À¯ÀüÀÚ µ¹¿¬º¯ÀÌ °ËÃâ, °¨¿° ÀÎÀÚ È®ÀÎ, Áúº´ ÁøÇà ¸ð´ÏÅ͸µ µîÀÇ Áø´Ü¿¡ ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. Á¤¹ÐÀÇ·á°¡ ÇコÄɾîÀÇ Ç¥ÁØ Á¢±Ù¹ýÀÌ µÇ¸é¼ Á¤È®ÇÑ DNA, RNA, ´Ü¹éÁú ºÐ¼®ÀÇ Çʿ伺ÀÌ ÀÓ»ó ÇöÀå¿¡¼ Àü±â¿µµ¿ ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¼Â°, Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸·Î ÀÎÇØ ÀÌ ±â¼úÀÌ ´õ Ä£¼÷Çϰí, ´õ ºü¸£°í, ´õ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÚµ¿ÈµÈ °Ö Àü±â¿µµ¿ ½Ã½ºÅÛ, ÇÁ¸®Ä³½ºÆ® °Ö, ÷´Ü À̹Ì¡ ±â¼úÀº ±âÁ¸ÀÇ Àü±â¿µµ¿ °øÁ¤¿¡ ÇÊ¿äÇÑ º¹À⼺°ú ½Ã°£À» ÁÙ¿©ÁÖ¾î Á¡Á¡ ´õ ¸¹Àº ¿¬±¸ÀÚ¿Í ÀÓ»óÀǵéÀÌ ÀÌ ±â¼úÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ¶ÇÇÑ Áø´Ü, ÀǾàǰ °³¹ß ¹× ¿¬±¸ Àû¿ë¿¡ ÇʼöÀûÀÎ °á°úÀÇ Á¤È®¼º°ú ÀçÇö¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·á ¹× ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ °Ö Àü±â¿µµ¿ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚµéÀÌ Áúº´°ú °ü·ÃµÈ ƯÁ¤ À¯ÀüÀÚ ¸¶Ä¿³ª ´Ü¹éÁú ½Ã±×´Ïó¸¦ È®ÀÎÇϰíÀÚ ÇÒ ¶§, °Ö Àü±â¿µµ¿Àº ÀÌ·¯ÇÑ »ýü ºÐÀÚ¸¦ ºÐ¸®ÇÏ°í ½Ã°¢ÈÇϱâ À§ÇÑ Áß¿äÇÑ ±â¼ú·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¾Ï ¿¬±¸¿¡¼ Àü±â¿µµ¿Àº ´Ü¹éÁúÀÇ ¹ßÇö ÆÐÅÏÀ» Á¶»çÇϰí ÀáÀçÀûÀÎ Ä¡·á Ç¥ÀûÀ» ½Äº°ÇÏ´Â µ¥ »ç¿ëµÇ¾î ÷´Ü Àü±â¿µµ¿ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ, »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎÀÇ ÀçÁ¤ Áö¿ø°ú ÅõÀÚ°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±¹°¡µéÀÌ ÇコÄÉ¾î ¹× ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ÀÏȯÀ¸·Î À¯Àüü ¿¬±¸ ¹× ºÐÀÚÁø´Ü¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Çмú, ÀÓ»ó ¹× Á¦¾à ½ÇÇè½Ç¿¡¼ °Ö Àü±â¿µµ¿ ±â¼úÀÇ Ã¤ÅÃÀ» È®´ëÇÏ´Â µ¥ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.
°á·ÐÀûÀ¸·Î, °Ö Àü±â¿µµ¿ ½ÃÀåÀº ºÐÀÚ ¿¬±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Áø´Ü ±â¼úÀÇ ¹ßÀü, ¸ÂÃãÇü ÀÇ·áÀÇ Çʿ伺, º¸´Ù ºü¸£°í È¿À²ÀûÀÎ Àü±â¿µµ¿ ½Ã½ºÅÛÀÇ °³¹ß·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼°¡ Áö¼ÓµÇ´Â °¡¿îµ¥, °Ö Àü±â¿µµ¿Àº ½ÇÇè½Ç ¹× ÀÓ»ó ½ÇÇè½Ç¿¡¼ ÇÙ½É ±â¼ú·Î ³²¾Æ ºÐÀÚ»ý¹°Çп¡ ´ëÇÑ ÀÌÇØ¸¦ ³ôÀ̰í ÀÇ·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀÔ´Ï´Ù.
ºÎ¹®
ÃÖÁ¾»ç¿ëÀÚ(½ÇÇè½Ç ¿¬±¸, Á¦¾à&:»ý¸í°øÇÐ ±â¾÷, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)
Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 41°Ç)
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- C.B.S. Scientific Company
- GE Healthcare
- Harvard Bioscience, Inc.
- Helena Laboratories Corporation
- Hoefer, Inc.
- Lonza Group AG
- MilliporeSigma
- PerkinElmer, Inc.
- SCIEX
- Sebia SA
- SERVA Electrophoresis GmbH
- Shimadzu Corporation
- Sysmex Partec GmbH
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä
- ÁÖ¿ä ±â¾÷
- ½ÃÀå µ¿Çâ°ú ¼ºÀå ÃËÁø¿äÀÎ
- ¼¼°è ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ºÐ¼®
- ¹Ì±¹
- ij³ª´Ù
- ÀϺ»
- Áß±¹
- À¯·´
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ¿µ±¹
- ½ºÆäÀÎ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- È£ÁÖ
- Àεµ
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¾Æ¸£ÇîÆ¼³ª
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- 秵- À̶õ
- À̽º¶ó¿¤
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- ±âŸ Áßµ¿
- ¾ÆÇÁ¸®Ä«
Á¦4Àå °æÀï
ksm
Global Gel Electrophoresis Market to Reach US$2.5 Billion by 2030
The global market for Gel Electrophoresis estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Pharma & Biotech Companies End-Use segment is estimated at 5.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$482.8 Million While China is Forecast to Grow at 8.2% CAGR
The Gel Electrophoresis market in the U.S. is estimated at US$482.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$575.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
Global Gel Electrophoresis Market - Key Trends and Drivers Summarized
Why Is Gel Electrophoresis Critical in Modern Molecular Biology and Research?
Gel electrophoresis is a fundamental technique in molecular biology and biochemistry, playing a vital role in the analysis and separation of nucleic acids (DNA, RNA) and proteins. But why is this technique so crucial in modern scientific research? Gel electrophoresis is essential because it allows scientists to separate molecules based on their size, charge, or shape, making it possible to visualize, quantify, and analyze genetic material and proteins with precision. This technique is widely used in a range of applications, from genetic fingerprinting and forensic analysis to gene cloning, genetic engineering, and protein research.
In DNA analysis, gel electrophoresis is particularly important for verifying the success of polymerase chain reactions (PCR) or restriction enzyme digestion, which are essential steps in genetic studies and molecular cloning. Researchers use it to confirm the presence, size, and integrity of DNA fragments, enabling them to map genes, study genetic mutations, or even identify individuals in forensic cases. In protein studies, gel electrophoresis helps in determining the purity, molecular weight, and structure of proteins, making it indispensable for drug development and diagnostic applications. Given its versatility and precision, gel electrophoresis remains a cornerstone of molecular biology research, enabling breakthroughs in genomics, proteomics, and personalized medicine.
How Are Technological Advancements Enhancing Gel Electrophoresis?
Technological advancements in gel electrophoresis are significantly improving its precision, speed, and ease of use, making it an even more powerful tool for molecular and biochemical research. One of the key innovations is the development of automated electrophoresis systems. These systems integrate all the steps of electrophoresis—from sample loading to imaging—into a streamlined, automated process. Automated systems reduce human error, provide consistent results, and allow researchers to analyze multiple samples simultaneously, improving throughput and efficiency in laboratories.
Another major advancement is the improvement in gel materials. Traditional agarose and polyacrylamide gels are still widely used, but newer gels have been developed with better resolution and faster run times. For example, precast gels come pre-prepared, eliminating the need for researchers to prepare their own gels, which can be time-consuming and error-prone. Precast gels also offer more uniformity in thickness and composition, ensuring more accurate and reproducible results. Additionally, the development of gradient gels, which vary in density, allows for more precise separation of molecules of different sizes in the same sample, improving the clarity of results.
Fluorescent staining techniques represent another breakthrough in gel electrophoresis. Traditional stains like ethidium bromide have been largely replaced by safer and more sensitive fluorescent dyes that can detect much smaller quantities of nucleic acids and proteins. These dyes bind to the molecules of interest and, when exposed to specific wavelengths of light, produce a bright fluorescent signal, making it easier to detect even trace amounts of material. This sensitivity is particularly valuable in applications like next-generation sequencing or proteomics, where precise quantification is essential.
Additionally, advancements in electrophoresis buffers and running conditions, such as temperature-controlled systems, help prevent the degradation of sensitive biomolecules during the separation process, further improving the reliability of gel electrophoresis. These technological innovations are making gel electrophoresis more robust, accurate, and user-friendly, expanding its use in cutting-edge research fields such as genomics, proteomics, and molecular diagnostics.
Why Is Gel Electrophoresis Essential for DNA, RNA, and Protein Analysis in Research and Diagnostics?
Gel electrophoresis is indispensable for the analysis of DNA, RNA, and proteins, particularly in research and diagnostic settings where precision and accuracy are paramount. For DNA and RNA analysis, gel electrophoresis allows scientists to separate nucleic acids by size, which is crucial for visualizing genetic material after techniques like PCR or restriction enzyme digestion. This separation helps researchers confirm the presence of specific DNA or RNA fragments, assess their quality, and determine their size—key factors in gene mapping, cloning, and sequencing. In forensic science, gel electrophoresis is also used for DNA fingerprinting, where the unique patterns of DNA fragments can be used to identify individuals or verify relationships.
In protein research, gel electrophoresis is essential for analyzing protein composition, structure, and function. Techniques like SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) allow proteins to be separated based on their molecular weight, enabling scientists to study individual proteins in complex mixtures. This is critical for drug development, where researchers need to isolate and study specific proteins involved in disease pathways. Gel electrophoresis is also used to assess protein purity and to detect post-translational modifications, both of which are important in biochemical research and the development of therapeutics.
Moreover, gel electrophoresis plays a vital role in diagnosing genetic disorders, cancers, and infections. For example, it is commonly used to identify mutations in genes that are linked to diseases like cystic fibrosis or sickle cell anemia. By separating and analyzing DNA or RNA from patient samples, clinicians can pinpoint specific genetic abnormalities, allowing for accurate diagnosis and personalized treatment plans. Additionally, electrophoresis-based techniques like Western blotting are used in clinical diagnostics to detect proteins associated with diseases, such as antibodies in autoimmune disorders or viral proteins in infections like HIV.
In summary, gel electrophoresis is a fundamental tool in both research and diagnostics, providing the ability to separate and analyze biological molecules with a high degree of precision. Its versatility and effectiveness in handling nucleic acids and proteins make it a critical technique for advancing our understanding of genetics, disease mechanisms, and drug development.
What Factors Are Driving the Growth of the Gel Electrophoresis Market?
The gel electrophoresis market is experiencing strong growth, driven by a combination of increasing demand for molecular diagnostics, advancements in genomic research, and the need for more efficient and precise laboratory techniques. One of the primary drivers is the expanding field of genomics and proteomics, which relies heavily on electrophoresis for DNA, RNA, and protein analysis. As researchers delve deeper into gene expression studies, genetic mapping, and personalized medicine, the demand for reliable and accurate techniques like gel electrophoresis continues to rise.
Second, the growing need for molecular diagnostics is fueling market growth. With the increasing prevalence of genetic disorders, cancers, and infectious diseases, healthcare providers are turning to molecular diagnostic techniques to accurately identify and treat these conditions. Gel electrophoresis is commonly used in diagnostics to detect genetic mutations, identify infectious agents, and monitor the progression of diseases. As precision medicine becomes a standard approach in healthcare, the need for accurate DNA, RNA, and protein analysis is driving the adoption of electrophoresis technologies in clinical settings.
Third, technological advancements in electrophoresis systems are making the technique more accessible, faster, and easier to use. Automated gel electrophoresis systems, pre-cast gels, and advanced imaging techniques are reducing the complexity and time required for traditional electrophoresis processes, attracting more researchers and clinicians to adopt this technology. These innovations are also improving the accuracy and reproducibility of results, which is essential for applications in diagnostics, drug development, and research.
Additionally, the increasing focus on personalized medicine and biomarker discovery is contributing to the growth of the gel electrophoresis market. As researchers seek to identify specific genetic markers or protein signatures linked to diseases, gel electrophoresis remains a key technique for separating and visualizing these biomolecules. In cancer research, for example, electrophoresis is used to study protein expression patterns and identify potential therapeutic targets, driving the demand for advanced electrophoresis systems.
Moreover, government funding and investments in life science research are further propelling market growth. Many countries are investing heavily in genomics research and molecular diagnostics as part of their healthcare and research initiatives, leading to greater adoption of gel electrophoresis technologies in academic, clinical, and pharmaceutical laboratories.
In conclusion, the gel electrophoresis market is growing due to the rising demand for molecular research, advancements in diagnostic technologies, the need for personalized medicine, and the development of faster, more efficient electrophoresis systems. As these trends continue, gel electrophoresis will remain a cornerstone technique in both research and clinical laboratories, playing a critical role in advancing our understanding of molecular biology and improving healthcare outcomes.
SCOPE OF STUDY:
The report analyzes the Gel Electrophoresis market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
End-Use (Laboratory Research, Pharma & Biotech Companies, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 41 Featured) -
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- C.B.S. Scientific Company
- GE Healthcare
- Harvard Bioscience, Inc.
- Helena Laboratories Corporation
- Hoefer, Inc.
- Lonza Group AG
- MilliporeSigma
- PerkinElmer, Inc.
- SCIEX
- Sebia SA
- SERVA Electrophoresis GmbH
- Shimadzu Corporation
- Sysmex Partec GmbH
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Gel Electrophoresis - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Growing Use of Gel Electrophoresis in Genomics and Proteomics Drives Market Growth
- Role of Gel Electrophoresis in Drug Discovery and Development Processes
- Market Opportunities in Emerging Biotechnology Markets
- Consumer Demand for Faster, More Accurate Diagnostic Techniques
- Advances in Microfluidics and Miniaturization of Electrophoresis Equipment
- Environmental and Safety Considerations in Electrophoresis Media Disposal
- Role of Gel Electrophoresis in Quality Control in Food and Beverage Industry
- Future Trends: Towards Chip-based Electrophoresis and Lab-on-a-Chip Technologies
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Gel Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 7: World 15-Year Perspective for Laboratory Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 10: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 14: USA Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 15: USA Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 16: USA 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- CANADA
- TABLE 17: Canada Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 18: Canada Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 19: Canada 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- JAPAN
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 20: Japan Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 21: Japan Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 22: Japan 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- CHINA
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 23: China Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 24: China Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 25: China 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- EUROPE
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 26: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: Europe Historic Review for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 28: Europe 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 29: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 30: Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 31: Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- FRANCE
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 32: France Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 33: France Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 34: France 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- GERMANY
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 35: Germany Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 36: Germany Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 37: Germany 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ITALY
- TABLE 38: Italy Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: Italy Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: Italy 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 41: UK Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: UK Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: UK 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 44: Spain Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: Spain Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: Spain 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 47: Russia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Russia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Russia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Rest of Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Rest of Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 54: Asia-Pacific Historic Review for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- AUSTRALIA
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 59: Australia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Australia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: Australia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- INDIA
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 62: India Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: India Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: India 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 65: South Korea Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: South Korea Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: South Korea 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: Rest of Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 71: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 72: Latin America Historic Review for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: Latin America 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 74: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 77: Argentina Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Argentina Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Argentina 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 80: Brazil Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Brazil Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: Brazil 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 83: Mexico Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Mexico Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: Mexico 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Rest of Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: Rest of Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 89: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 90: Middle East Historic Review for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: Middle East 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 92: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- IRAN
- TABLE 95: Iran Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Iran Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Iran 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 98: Israel Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Israel Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Israel 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Saudi Arabia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Saudi Arabia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 104: UAE Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: UAE Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: UAE 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Rest of Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: Rest of Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
- AFRICA
- Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 110: Africa Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Africa Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: Africa 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
IV. COMPETITION